<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> have been associated with occurrence of arterial and venous thrombotic events and fetal loss, which together constitute the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>However, <z:mp ids='MP_0001914'>bleeding</z:mp> is rare in this syndrome </plain></SENT>
<SENT sid="2" pm="."><plain>We report a case of <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) with APS complicated simultaneously by thrombotic and hemorrhagic events </plain></SENT>
<SENT sid="3" pm="."><plain>A 34-year-old woman was a known case of diffuse proliferative <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> associated with APS, on treatment with <z:chebi fb="0" ids="50858">corticosteroids</z:chebi>, <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>She presented in February 2004 with severe <z:hpo ids='HP_0001903'>anemia</z:hpo>, <z:hpo ids='HP_0000132'>menorrhagia</z:hpo>, <z:hpo ids='HP_0000225'>gingival bleeding</z:hpo> and <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0000572'>loss of vision</z:hpo> in the left eye </plain></SENT>
<SENT sid="5" pm="."><plain>Investigations revealed a <z:mp ids='MP_0008817'>hematoma</z:mp> in the psoas muscle with <z:mp ids='MP_0005048'>thrombosis</z:mp> of the inferior vena cava and occlusion of the <z:chebi fb="46" ids="15035">retinal</z:chebi> vein </plain></SENT>
<SENT sid="6" pm="."><plain>Blood tests revealed a strongly positive <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, <z:e sem="disease" ids="C0015523" disease_type="Disease or Syndrome" abbrv="">factor XI deficiency</z:e> (35%) and decrease of free protein S (44%) </plain></SENT>
<SENT sid="7" pm="."><plain>Factor XI inhibitor, anti-prothrombin, and anti-protein S antibodies were absent </plain></SENT>
<SENT sid="8" pm="."><plain>The patient was treated with <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> and six pulses of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, which resulted in a rapid disappearance of <z:mp ids='MP_0001914'>bleeding</z:mp>, reduction of <z:mp ids='MP_0008817'>hematoma</z:mp> and normalization of <z:hpo ids='HP_0001871'>hematological abnormalities</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>She was maintained on <z:chebi fb="0" ids="50858">corticosteroids</z:chebi>, <z:chebi fb="2" ids="2948">azathioprine</z:chebi> and <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> agents were introduced </plain></SENT>
<SENT sid="10" pm="."><plain>After a follow-up of 28 months, there was no recurrence of <z:mp ids='MP_0001914'>bleeding</z:mp>, the <z:mp ids='MP_0005048'>thrombosis</z:mp> had resolved, and there was a decrease in the levels of circulating <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> as well as anticardiolipin antibodies </plain></SENT>
</text></document>